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winning Combination for Tissue 
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Department of Applied Science and Technology, Institute of Materials Physics and Engineering, Politecnico di Torino,  
Turin, Italy
In the last few decades, we have assisted to a general increase of elder population 
worldwide associated with age-related pathologies. Therefore, there is the need for new 
biomaterials that can substitute damaged tissues, stimulate the body’s own regenerative 
mechanisms, and promote tissue healing. Porous templates referred to as “scaffolds” are 
thought to be required for three-dimensional tissue growth. Bioceramics, a special set of 
fully, partially, or non-crystalline ceramics (e.g., calcium phosphates, bioactive glasses, 
and glass–ceramics) that are designed for the repair and reconstruction of diseased 
parts of the body, have high potential as scaffold materials. Traditionally, bioceramics 
have been used to fill and restore bone and dental defects (repair of hard tissues). More 
recently, this category of biomaterials has also revealed promising applications in the 
field of soft-tissue engineering. Starting with an overview of the fundamental require-
ments for tissue engineering scaffolds, this article provides a detailed picture on recent 
developments of porous bioceramics and composites, including a summary of common 
fabrication technologies and a critical analysis of structure–property and structure–func-
tion relationships. Areas of future research are highlighted at the end of this review, with 
special attention to the development of multifunctional scaffolds exploiting therapeutic 
ion/drug release and emerging applications beyond hard tissue repair.
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iNTRODUCTiON
The term “tissue engineering” was up to the mid 1980s loosely applied in the literature in cases 
of surgical manipulation of tissues and organs or in a broader sense when prosthetic devices or 
biomaterials were used. A clear definition was given by Langer and Vacanti (1993) as follows:
Tissue engineering is an interdisciplinary field that applies the principles of engineering 
and life science toward the development of biological substitutes that restore, maintain, or 
improve the tissue function.
Without a doubt, tissue engineering aims to provide a permanent solution to the replacement 
of tissues that are either defective or have been lost due to different pathological conditions, and 
it has emerged as a promising alternative to tissue or organ transplantation. This approach uses 
interdisciplinary tools to produce devices that have the potential to integrate and regenerate a 
TABLe 1 | Design criteria for tissue engineering scaffolds.
Requirements Description
(i) Geometry It must initially fill complex 3-D defects, subsequently 
guiding the tissue to match the original 3-D anatomy
(ii) Bioactivity Stimulation of rapid tissue attachment to the implant 
surface (without formation of scar/fibrous tissue) and 
creation of a stable long-term bonding that prevents 
micromotion at the interface and the onset of an 
inflammatory response
(iii) Biocompatibility Ability to support normal cellular activity including 
molecular signaling systems without any local and/or 
systemic toxic effects to the host tissue
(iv) Chemical and 
biological stability/
biodegradability
Depending on the specific application; if the scaffold 
must remain in situ indefinitely, materials with high 
stability must be selected; conversely, if it is intended 
to be a temporary device, the scaffold must degrade 
gradually over a predetermined period of time and be 
replaced by the natural host tissue
(v) Porous structure The scaffold must possess an interconnected porous 
structure with a large surface-to-volume ratio and 
pore size of at least 100 μm in diameter (ideal for 
bone repair) to allow cell penetration, tissue in-growth, 
facilitate vascularization of the construct, and nutrient 
transport
(vi) Mechanical 
competence/
compliance
The mechanical performance of the scaffold, which is 
determined by both the properties of the biomaterial 
and the porous structure, must be sufficient to 
withstand implantation handling and support the loads 
and stresses that the new tissue will ultimately bear. 
Adequate elastic compliance (low stiffness) with soft 
tissue is required for non-osseous applications
(vii) Biological 
properties
Special properties, such as the promotion of 
angiogenesis, stimulation of cell differentiation, and 
antibacterial effect, can be achieved by the release 
of appropriate ions from the scaffold material. These 
added values are typically imparted to bioactive glass 
scaffolds by carefully designing the glass composition
(viii) Fabrication The scaffold should be easily tailored in size and shape 
to the diseased or injured area that the new tissue will 
replace
(ix) Commercialization 
potential
The scaffold should be produced with an automated 
technique in a reproducible manner; it should be 
fabricated and sterilized according to international 
standards for commercial production and clinical use
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specific functional tissue upon implantation. A key component 
of this strategy is a synthetic framework referred to as scaffold, 
which serves as a guiding two- or three-dimensional (2- or 3-D) 
structure for both hard- and soft-tissue development both in vitro 
and in vivo. Due to its open system of interconnected pores, the 
scaffold provides a mechanically stable environment that can 
host the required cells and biological components (seeded in the 
laboratory prior to implantation), allow cell migration, adhesion 
and growth, and support the organization of the growing tissue 
when implanted in vivo (Nerem, 1991). This is further enhanced 
by the use of “signaling,” which is another building block of tissue 
engineering. Signaling involves biochemical and biomechanical 
signals (delivered by the scaffold), which activate in vivo mecha-
nisms of tissue regeneration, coaxing the cells into creating viable 
tissues and, thus, determining whether the scaffold turns into 
integrated tissue (Rutenberg et al., 2004; Johnson et al., 2007).
Many different materials have been investigated and engi-
neered (natural and synthetic, bioresorbable, and permanent) 
to construct scaffolds. Among these, bioceramics have been 
extensively considered since these materials generally show bet-
ter tissue responses compared to polymers and metals (Hench, 
1998). Some bioceramics, such as hydroxyapatite (HA) and 
alumina, are intended to be permanent devices, thus they do not 
release their components into the human body and are expected 
to generate no foreign body reactions. On the other hand, if 
designed as resorbable biomaterials (e.g., most bioactive glasses) 
with various resorption kinetics (from days to months), their ion 
dissolution products (typically Ca, Si, Na, and phosphate ions) 
can be usually processed via normal metabolism (Habibovic and 
Barralet, 2011) or even exploited to exert a desired therapeutic 
effect, such as promotion of angiogenesis and antibacterial prop-
erties (Gerhardt et al., 2011; Hoppe et al., 2011; Mourino et al., 
2012; Vargas et al., 2013).
Given the inorganic nature and mechanical rigidity of bioce-
ramics, their traditional fields of application have been related 
to hard tissue repair, such as bone and teeth. However, several 
studies have also demonstrated the potential of bioceramics as 
an innovative route to regenerate various types of damaged soft 
tissues (Baino et al., 2016b; Miguez-Pacheco et al., 2015a).
This article will look at bioceramic materials used as scaf-
folds for hard- and soft-tissue engineering. First, basic scaffold 
requirements are examined and an overview of bioceramics 
used to produce a variety of scaffolds is given. Then, the main 
fabrication technologies used for making scaffolds are presented 
discussing both advantages and limitations. Further directions 
for the research are finally discussed, highlighting the promise of 
multifunctional engineered systems that combine the “conven-
tional” proprieties of bioceramics and new, smart added values for 
improved therapeutic action (e.g., ion release and drug delivery).
SCAFFOLD ReQUiReMeNTS AND 
CRiTiCAL iSSUeS
Tissue engineering scaffolds have been widely studied with the 
hope of designing implantable biomaterials that can produce the 
most appropriate host response in which the clinical situation 
demands while supporting the growth and regeneration of com-
plex 3-D tissues. There are several widely accepted requirements 
that should characterize an ideal scaffold (Hutmacher, 2000; 
Jones et  al., 2007; Gerhardt and Boccaccini, 2010; Baino and 
Vitale-Brovarone, 2011), as summarized in Table 1.
A major difficulty in the design of scaffolds is to simultane-
ously tailor these requirements due to their competing nature 
in fulfilling host tissue demands, namely, if a specific requisite 
is accomplished, another one might in turn be negatively 
affected.
A crucial aspect for the successful outcome of scaffolds for 
load-bearing applications (e.g., bone tissue repair) is the need to 
balance the porosity of a scaffold with its mechanical proprieties 
(Vitale-Brovarone et al., 2009). As described in Table 1, a highly 
interconnected porous structure (typically a pore content above 
50  vol.%) is essential to enable full integration of the scaffold 
once it is implanted. However, porosity affects the mechanical 
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competence of the component, as strength and stiffness progres-
sively diminish when the volume fraction of porosity is increased 
(Gibson, 1989).
If the scaffold is intended to be bioresorbable, the achievement 
of mechanical competence becomes a further hurdle since degra-
dable materials tend to be mechanically more and more fragile 
over time. Additional complications in the development of biore-
sorbable scaffolds are (i) the maintenance of strength and stability 
of the interface during the degradation period and replacement 
by the natural host tissue and (ii) matching the rate of resorption 
with that of the expected specific tissue regeneration. It is also 
important that the breakdown products of the biomaterial can be 
readily metabolized without causing any local or systemic adverse 
reaction (Hoppe et al., 2011).
Another aspect that is worth mentioning concerns the limita-
tion of elastic modulus mismatch, which is crucial for the long-
term success of implant bonding to both hard and soft tissues. 
Several studies demonstrated that the discontinuous change in 
elastic properties at the tissue–implant interface results in large 
stress gradients to the host tissue ultimately leading to failure of 
the implanted material (Hench and Greenspan, 2013).
Optimization of all the physicochemical parameters sum-
marized in Table  1 is an extremely difficult task due to their 
complex and still partially unexplained interlocking. The rate and 
quality of tissue integration have been related to a dependence on 
scaffold pore size, porosity volume fraction, and pore intercon-
nection (Karageorgiu and Kaplan, 2005). Moreover, the role of 
strut microstructure and pore geometry has to be considered 
with respect to their influence on entrapment and recruitment 
of growth factors in addition to their influence on scaffold 
mechanics. Deconvoluting the relative effects of these parameters 
is complicated by the bioactivity of many bioceramics, which is 
mediated through two principal mechanisms: (i) directly through 
dissolution and release of ionic products in  vitro and in  vivo, 
elevating local concentrations of soluble species that interact 
directly with local cells or influence cell behavior by their effect 
on local pH and (ii) indirectly through the influence that surface 
chemistry will have on protein adsorption, growth factor entrap-
ment, and subsequent cell attachment and function. A valuable 
picture on these important issues in view of optimizing scaffold 
design and fabrication has been recently given by Hing (2005).
A highly challenging field of research concerns the strategies 
for imparting special “biological” properties to tissue engineer-
ing scaffolds, with particular reference to the use of bioactive 
glasses. It has been demonstrated that key mechanisms leading 
to enhanced new bone growth are related to the controlled release 
of ionic dissolution products (e.g., soluble silica and calcium ions) 
from the degrading bioactive glass (Hench, 2009). Specifically, 
a series of studies have shown that bioactive silicate glasses and 
their ionic dissolution products enhance osteogenesis by regulat-
ing osteoblast proliferation, differentiation, and gene expression 
(Xynos et al., 2000, 2001; Jell and Stevens, 2006; Jell et al., 2008). 
Sun et  al. (2007) showed that 45S5 Bioglass® promotes human 
osteoblast proliferation: in the presence of critical concentrations 
of Si and Ca ions, within 48 h osteoblasts that are capable of differ-
entiating into a mature osteocyte phenotype begin to proliferate 
and regenerate new bone and, at the same time, osteoblasts that 
are not in the correct phase of the cell cycle and unable to proceed 
toward differentiation are switched into apoptosis by the ionic 
dissolution products.
The relative contribution of specific ion dissolution products 
from bioactive glasses or Si-substituted calcium phosphates to 
osteogenesis have been controversially debated in the literature 
(Bohner, 2009; Hoppe et al., 2011). It has been hypothesized that 
the high Si concentration from bioactive glass could be a major 
factor in stimulating osteoblasts to grow quickly, which might be 
effective for melt-derived bioactive glasses (Xynos et  al., 2001; 
Sun et al., 2007). However, Bielby et al. (2004) found no signifi-
cant differences in the proliferation of human primary osteoblasts 
grown in conditioned cell culture media containing similar Ca, 
P, and Na ions but different Si ion concentrations released from a 
sol–gel bioactive glass. Therefore, further studies are required to 
gain quantitative knowledge and to confirm the mechanisms by 
which ion dissolution products from bioactive glass may affect 
gene expression in bone cells.
Recent findings also indicate that controlled release of low con-
centrations of ionic dissolution products from bioactive glasses 
can induce angiogenesis that plays a key role in the regeneration 
process of both hard and soft tissue (Gerhardt et al., 2011; Vargas 
et al., 2013). The role of angiogenic and osteogenic factors in the 
adaptive response and interaction of osteoblasts and endothelial 
cells during the processes of bone development and bone repair 
has been reviewed in detail by Kanczler and Oreffo (2008).
Early studies suggesting that the ability of bioactive glasses to 
induce differentiation of non-osseous cells (e.g., muscle precursor 
cells exposed to phosphate glasses) have been recently reported 
(Ahmed et al., 2004).
BiOCeRAMiCS: A SHORT OveRview
Bioceramics is a large class of specially designed ceramics for 
the repair and reconstruction of diseased or damaged parts of 
the body. Current forms of application in clinical use include 
solid pieces (used, for instance, in the reconstruction of middle 
ear ossicles or as load-bearing components of joint prostheses), 
powders and granules for bone filling, coatings on metal joint 
prostheses, injectable formulations (bone cement), and porous 
scaffolds (Figure 1). Based on their tissue response, bioceram-
ics can be classified into three major families: nearly inert (e.g., 
alumina and zirconia), bioactive (e.g., bioactive glass), and 
resorbable ceramics [e.g., β- and α-tricalcium phosphate (TCP)] 
(Hench, 1996). Nearly, inert ceramics are generally used as 
femoral heads and acetabular cups for hip replacement as well 
as to fabricate dental implants; however, usually these materials 
are not used as scaffolds due to their inertness that triggers the 
formation of a 1- to 3-μm thick “protective” fibrous capsule on 
the surface of the implant. Even if there is no aggressive foreign 
body response, there is no bond between the implant and the host 
tissue (Hench, 1996).
The ability of creating a stable bond with the host tissue is of 
primary importance in the selection of bioceramics for making 
scaffolds. In this regard, bioactive as well as bioresorbable ceram-
ics represent a valuable solution. Furthermore, the latter ones 
exhibit the added value of degrading gradually over a period of 
FiGURe 1 | examples of commercial bioceramics for medical 
applications: powders and granules for use as bone fillers (typically 
calcium phosphates or bioactive glass), hemispherical acetabular 
cup (alumina) for hip joint prosthesis, hydroxyapatite coating on 
femoral metal stem, porous scaffolds (usually calcium phosphates 
or bioactive glass/glass–ceramic). Image reproduced from ©  
Dorozhkin (2010a).
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time while being replaced by the natural host tissue and, therefore, 
disappear once their task of acting as templates for new tissue 
has been completed (Baino and Vitale-Brovarone, 2011; Fu et al., 
2011a,b).
The following sections focus on the main types of bioceramics 
that are currently used to fabricate scaffolds by schematically 
grouping the materials in their specific class from a microstructural 
viewpoint: crystalline ceramics, bioactive glasses, glass–ceramics, 
and composites. Applications and clinical developments are also 
shortly discussed.
Crystalline Ceramics
The major representatives of this class are calcium phosphates 
that are among the most widely used crystalline ceramics for bone 
tissue regeneration. This is due to their exceptional properties that 
include (i) similarity, in terms of structure and chemical composi-
tion, to the mineral phase of bone, and (ii) osteoconductivity, i.e., 
the ability of providing a biocompatible interface along with bone 
migrates, and thus bonds to the host tissue without the formation 
of scar tissue (Cao and Hench, 1996; LeGeros, 2002).
Synthetic HA (Ca10(PO4)6(OH)2) has a stoichiometric 
calcium-to-phosphate ratio of 1:67 and, from a crystallographic 
point of view, is the calcium phosphate phase most similar to 
natural bone apatite. Because of its excellent biocompatibility 
and osteoconductivity, HA is successfully used as bone filler in 
the form of cement or granules and in the form of coatings on 
metallic joint prostheses. However, its use as a scaffold material 
is limited because of its low mechanical properties and extremely 
slow resorption rate (Barrere et al., 2006).
It is partly for this reason that other calcium phosphates have 
emerged with different degrees of solubility depending mainly 
on the calcium-to-phosphorous ratio (the rate of dissolution 
increases with decreasing Ca/P ratio) as well as on the crystal-
lographic structure (Hench, 1996; Dorozhkin, 2007, 2010a,b). 
The interested reader is addressed to specific publications deal-
ing with calcium phosphate bioceramics (Legeros et  al., 2003; 
Dorozhkin, 2012).
A common drawback to all calcium phosphate bioceramics 
produced in a porous form is their low mechanical properties 
(brittleness, low fatigue strength) that largely limit their clinical 
use to non-major load-bearing parts of the skeleton. We have to 
consider that calcium phosphate scaffolds are often consolidated 
by sintering that, however, does not occur under a viscous flow 
regime, and thus may not lead to full densification of scaffold 
struts. Other materials, such as a few bioactive glass–ceramics 
and composites, seem to be more suitable for fabricating high-
strength, tough scaffolds (Baino and Vitale-Brovarone, 2011; Fu 
et al., 2011a,b).
Besides calcium phosphates, alumina is another well-known 
example of crystalline ceramic that has been widely used for 
decades to fabricate components of hip and knee joint prostheses 
(femur head, acetabular cup, and tibial plate) primarily due to 
its high-strength suitable for load-bearing applications, excellent 
wear resistance, and bioinertness (associated with maintenance 
of the desired physico-chemical and mechanical properties over 
time) (Rahaman et al., 2007). Porous alumina is clinically used 
only in the fabrication of orbital implants (spherical porous scaf-
folds) for enucleation that should allow fibrovascular ingrowth 
through the pore network and remain in the patient’s anophthal-
mic socket indefinitely without undergoing degradation (Baino 
et al., 2014; Baino and Vitale-Brovarone, 2015a).
Bioactive Glasses
It has been extensively proved that bioactive glasses are able to 
strongly bond to living tissues (primarily bone) creating a stable 
interface and to trigger a range of biological responses, such as 
tissue regeneration and angiogenesis while degrading over time 
(Hench, 2006; Jones, 2013).
These properties of bioactive glasses arise from a time-
dependent modification of their surface that occurs on exposure 
to physiological environment. The glass surface forms a biologi-
cally active layer of HA that provides the bonding interface with 
host tissues, while the dissolution products (Si, Na, Ca, phosphate 
ions, etc.) stimulate the cells to produce new tissue (Cao and 
Hench, 1996).
The first bioactive glass, belonging to the 45SiO2–24.5Na2O–
24.5CaO–6P2O5 (wt.%) system (45S5 Bioglass®), was developed 
by Prof. Larry Hench and coworkers in the late 1960s (Hench 
et al., 1971) and is in clinical use since 1985. Over the years, many 
other silicate, borate, and phosphate glasses have been proposed 
for biomedical applications, as reviewed elsewhere (Baino and 
Vitale-Brovarone, 2011; Rahaman et al., 2011).
Bioactive glasses are commonly produced by traditional 
melting-quenching routes or the sol–gel technique. Melt-derived 
glasses can be poured into molds to produce rods and bars or cast 
as components of various sizes and shapes. The melt can also be 
quenched in cold water to obtain a “frit,” i.e., granules and pieces of 
different sizes that can be easily powdered and further processed 
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to fabricate porous scaffolds (Baino and Vitale-Brovarone, 2011). 
Finally, the glasses can be also spun to fabricate glass fibers that 
in the last decade have attracted increasing interest for applica-
tion in soft-tissue engineering, especially the phosphate ones, as 
guides for muscle or nerve repair (Vitale-Brovarone et al., 2012a) 
as well as for the fabrication of glassy bone scaffolds (Gu et al., 
2013). For melt-derived silicate glasses, the silica content should 
be <60 mol.% to allow the glass to bond with bone (Wilson et al., 
1981). However, HA layer formation and bone bonding can be 
also achieved with glasses with up to 90 mol.% silica if the glass is 
obtained by a sol–gel process (Li et al., 1991). In general, sol–gel 
glasses were found to form a nanocrystalline HA surface layer 
more rapidly than melt-derived glasses due to the higher surface 
area available for ion-exchange phenomena (tens vs. few meter 
square per gram).
In the last decade, the advent of mesoporous bioactive glasses 
(MBGs) allowed combining superior bioactive properties (for-
mation of a surface HA layer within few hours from contact with 
biological fluids) and drug uptake/release abilities in a single, 
multifunctional biomaterial (Arcos and Vallet-Regí, 2013).
Glass–Ceramics
Glass can be converted by heating into a partially crystalline mate-
rial containing various kinds of crystalline phases with controlled 
size and content depending on the thermal treatment parameters. 
Generally, the resulting glass–ceramic material exhibits superior 
mechanical properties with respect to its parent glass, specifically 
higher elastic modulus, hardness, failure strength, and wear resist-
ance. Scaffolds are often produced by sintering, which requires 
glasses to be heated above their glass transition temperature in 
order to initiate localized flow. Many bioactive glasses, including 
45S5 Bioglass®, crystallize immediately above their glass transi-
tion temperature; therefore, sintered bioactive glass scaffolds are 
often glass–ceramic scaffolds (Gerhardt and Boccaccini, 2010; 
Baino and Vitale-Brovarone, 2011).
45S5 Bioglass®-derived scaffolds suffer from some 
drawbacks as the base glass tends to crystallize before full 
densification is achieved (sintering end), thereby originating 
extremely brittle glass–ceramic porous products; further-
more, scaffold bioactivity seems to be partially suppressed 
by the development of a sodium–calcium–silicate crystalline 
phase (Chen et  al., 2006). In the attempt to overcome these 
drawbacks, interesting results have been obtained by various 
research groups that proposed alternative glass–ceramics. For 
instance, Vitale-Brovarone et  al. (2007) used the bioactive 
glass CEL2 (45SiO2–26CaO–15Na2O–3P2O5–4K2O–7MgO 
mol.%) to fabricate foam-like glass–ceramic scaffolds exhibit-
ing compressive strength up to 1 MPa (porosity 70 vol.%) and 
an excellent biological compatibility with osteoblasts; more 
recently, the same research group successfully optimized the 
process parameters to obtain scaffolds with higher strength 
(5–6  MPa) within the typical range of cancellous bone 
(2–12 MPa) (Vitale-Brovarone et al., 2009; Baino et al., 2013). 
Glass–ceramic bone-like scaffolds based on the experimental 
glass SCNA (57SiO2–34CaO–6Na2O–3Al2O3 mol.%) can reach 
a compressive strength of 15 MPa (porosity around 65 vol.%), 
which makes them suitable for load-bearing applications but 
retain an extremely moderate bioactivity (Vitale-Brovarone 
et al., 2012b; Baino and Vitale-Brovarone, 2014).
Composites
A crucial aspect for the success of scaffolds in tissue engineering 
and regeneration of tissues is that the structure and properties 
of the scaffolds must be pertinent to the tissue concerned and 
the mechanical loads that it will experience in  vivo. Like most 
ceramic materials, bioceramics have the disadvantage of exhibit-
ing low fracture toughness (i.e., brittleness) and this could limit 
their use in load-bearing applications. Furthermore, their high 
stiffness may restrict the use of bioceramics in non-osseous appli-
cations, where adequate compliance with soft tissues is necessary 
(Miguez-Pacheco et al., 2015a).
One approach that aims to overcome these problems is the 
combination of bioceramics with polymers to produce a compos-
ite scaffold, which makes the most of both materials. Typically, 
bioceramics are added as fillers or coatings to the polymer matrix 
to improve its mechanical proprieties, i.e., to increase strength 
and stiffness as well as to effectively induce enhanced bioactivity 
(Mohamad Yunos et al., 2008).
Following an alternative strategy, Bretcanu et al. (2007) fab-
ricated porous composites by using a bioceramic scaffold (45S5 
Bioglass®) as a porous inorganic matrix and by coating it with 
poly(3-hydroxybutyrate) (P3HB). The polymer was specifically 
introduced to strengthen the 45S5 Bioglass® scaffold structure, 
in fact, the P3HB layer acted as a glue, thereby holding the 
inorganic particles together when the scaffold struts started to 
fail. The compressive strength of such a composite scaffold (up to 
1.5 MPa) was twice than that of bare 45S5 Bioglass® scaffolds (up 
to 0.4 MPa) (Chen et al., 2006).
Added values, such as drug uptake/release, are also provided to 
the composite if mesoporous glass particles are used as a second 
phase (Arcos and Vallet-Regí, 2013).
Both non-degradable and degradable polymers have been 
used in the fabrication of composite scaffolds; however, stable 
polymers often have low biocompatibility as they tend to become 
surrounded by a fibrous capsule once implanted. Therefore, 
there have been several attempts to create composites based 
on the combination of biodegradable polymers and bioceram-
ics. The first composites investigated were comprised of HA or 
TCP used as inorganic phases while poly(l-lactic acid) (PLLA), 
poly(d/l-lactic acid) (PDLLA), poly(glycolic acid) (PGA), and 
their copolymers (PLGA) as organic ones (Ambrosio et al., 2001; 
Deng et al., 2001; Kasaga et al., 2001; Xu et al., 2004). HA/polyeth-
ylene porous composites, marketed under the commercial name 
“Hapex,” are currently used in the clinical practice for the repair 
of orbital floor fractures (Tanner, 2010).
More recently, attention has moved toward nano-bioceramic/
polymer composites, which have the potential to improve inter-
action with the host tissue/cells (Erol-Taygun et al., 2013). In this 
regard, one of the most fascinating challenges is to develop smart 
composite biomaterials with nanoscale interaction between the 
bioactive inorganic phase and the organic one, so that the scaffold 
could degrade as a single material rather than having mismatched 
degradation rates of glass and polymer phase. As recently under-
lined by Jones (2009), this intimate interaction should allow 
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cells to come into contact with both phases at one time, and the 
scaffold should degrade at a single rate.
A special mention should be devoted to the so-called 
“star gels,” which are a particular type of organically 
modified silicates (“ormosils”) having an organic core sur-
rounded by flexible arms that are terminated in alkoxysilane 
groups able to form a silica-like network during the sol–gel 
process (Vallet-Regí et  al., 2006). These hybrid materials 
show bioactive properties and have fracture toughness 
higher than that of sol–gel glasses and comparable to that of 
cancellous bone, thus having promise for tissue engineering 
applications that require good long-term fatigue behavior 
(Manzano et al., 2006).
Fabrication of bioceramic/metal composites has been also 
reported where the ceramic phase is applied in the form of a 
coating. Metallic materials, such as stainless steel, titanium, and 
Co–Cr–Mo alloy, have become the materials of choice for load-
bearing prostheses due to high-strength, good fatigue resistance, 
and favorable machining properties. Some metallic materials, 
however, may produce adverse effects such as the release of sig-
nificant amounts of metal ions into the tissues, which may result 
in complications, such as inflammatory and immune reactions 
(Alvarez and Nakajima, 2009). Thus, there is a need to further 
improve the biocompatibility between metallic materials and 
host tissue (primarily bone). Wang et al. (2009) prepared porous 
TiNbZr alloy scaffold coated with calcium phosphate to improve 
osteoconductivity. Cell culture experiments showed that the 
surface-modified TiNbZr scaffolds were more favorable for the 
adhesion and proliferation of osteoblast-like cells compared to 
bare metal scaffolds.
FABRiCATiON TeCHNOLOGieS OF 
BiOCeRAMiC SCAFFOLDS
A wide range of processing routes has been proposed for the 
production of bioceramic porous scaffolds for tissue engineering. 
These include techniques developed ad hoc or often adapted from 
other contexts, such as foaming, solid freeform fabrication (SFF), 
starch consolidation, organic phase burning-out, and sponge 
replication.
These various methods provide a mean to control the 3-D 
structure of tissue engineering constructs, and processing can 
strongly influence various characteristics of the scaffold. Each 
method, in fact, is best suited for producing a specific range of 
pore size and distribution, interconnectivity and overall porosity 
in addition to strut thickness and orientation. Thus, the most 
appropriate technique must be accurately selected to meet the 
demands of the specific type of tissue (Colombo, 2006).
Moreover, each fabrication method differs in terms of overall 
cost, making some of them attractive for a large-scale production, 
while others are more appropriate for the development of value-
added products.
The following sections examine the main available techniques 
to fabricate bioceramic scaffolds, highlighting time by time the 
merits and drawbacks of each method. A comparison of these 
techniques is given in Table 2. An overview of the main methods 
used to fabricate bioceramic containing composite scaffolds is 
also provided.
Foaming Methods
Highly porous ceramics can be produced by dispersing a gas in 
the form of bubbles into a ceramic suspension or colloidal sols, 
followed by solidification, to obtain pores in the range of 20 μm up 
to 1–2 mm (Jones and Hench, 2003). The various foaming tech-
niques developed in the literature are based on two approaches: (i) 
incorporating an external gas by mechanical frothing, injection 
of a stream of gas, or introduction of an aerosol propellant and 
(ii) evolution of a gas in situ. The decisive step in direct foaming 
methods is the stabilization and setting of the wet foams. These, in 
fact, need to be set in order to maintain their porous morphology 
before heating at high temperature for sintering/ceramization. 
Furthermore, several transformations in the bubble structure 
might occur within the interval between foam generation and 
foam solidification. For instance, the gas bubbles initially have a 
spherical shape (nucleation phase) and later grow as polyhedral 
cells (Colombo, 2006). In order to retain the cellular morphology 
and prevent the collapse of the foamed structure, surfactants are 
generally used to stabilize the bubbles formed in the liquid phase 
as they reduce the surface tension of the gas–liquid interfaces. 
Surfactants stabilize the system for a limited period of time; 
hence, a further mechanism is then required to provide a more 
permanent form of stabilization (Sepulveda and Binner, 1999).
The incorporation of bubbles can be brought about by a variety 
of processing routes.
H2O2 foaming involves mixing ceramic powder with an 
aqueous solution of H2O2 as a foaming agent; then, the resulting 
mixture is cast into molds and stored into an oven at 60°C. At this 
temperature, H2O2 decomposes and the oxygen released tends to 
form bubbles in the slurry and, thus, gives rise to the foaming 
process. The sample is then sintered to obtain crystalline ceram-
ics, bioactive glass, and calcium phosphate scaffolds depending 
on the initial powders (Navarro et  al., 2004). By varying the 
amount of H2O2 incorporated and the thermal treatment, the 
percentage of porosity and pore size can be modulated. However, 
an intrinsic shortcoming of this foaming method is that pores 
are interconnected only in a laminar manner, resulting in poor 
interconnection in the direction perpendicular to the laminae (Li 
et al., 2002).
An alternative to H2O2 foaming is in  situ polymerization of 
an organic monomer (or gel-cast foaming). A high-solid-load 
aqueous ceramic suspension is prepared that also incorporates 
an organic monomer, which must be soluble in water (e.g., 
acrylates) together with an initiator and a catalyst to provide 
in  situ polymerization (Ortega et  al., 2002; Wu et  al., 2011b). 
The two latter ingredients are necessary to control the actual 
beginning of the polymerization reaction (i.e., the induction 
time – period of inactivity between the addition of reagents and 
the polymerization reaction onset), which, in the processing of 
porous ceramics, must take place during casting. After the addi-
tion of a foaming agent (surfactant), the suspension is mechani-
cally agitated to obtain a wet ceramic foam. The foam is cast into 
the appropriate mold and, after polymerization is complete, the 
green body is strong enough to be removed from the mold and 
TABLe 2 | Comparison of different techniques (listed in alphabetical order) for the fabrication of bioceramic scaffolds (non-composite) on the basis of 
their advantages and disadvantages.
Technique Advantages Disadvantages Reference
Foaming methods (general) Allows manufacturing of both closed and 
open-cell foams; good versatility of final part 
shapes, as the solution can be cast in molds 
without additional machining
Difficulty in achieving high 
interconnectivity; non-porous external 
surface
Jones and Hench (2003) and Colombo (2006)
H2O2 foaming Simple Low porosity control laminar pore 
structure with poor 3-D interconnection
Li et al. (2002) and Navarro et al. (2004)
Sol–gel foaming Hierarchical structure can be obtained 
(macroporous scaffold combined with 
ordered mesoporous texture)
Need for a high degree of control of 
the foam
Akkus et al. (2002) and Jones and Hench 
(2004)
In situ polymerization of 
organic monomer (gel-cast 
foaming)
Highly porous ceramic; high-strength 
properties due to the less flawed structure 
and dense struts and walls produced
Low pore interconnectivity Sepulveda and Binner (1999), Ortega et al. 
(2002), Ramay and Zhang (2003), and  
Wu et al. (2011b)
Organic phase burning-
out/space holder
High mechanical strength Difficult to obtain a homogeneous 
distribution of pores; poor 
interconnectivity
Baino et al. (2009) and Wu et al. (2009)
Solid freeform fabrication 
(SFF) (general)
Customized objects; reproducible Costly; resolution needs to be improved 
to the micro-scale
Hollister (2005)
SLA Complex internal features can be obtained Only applicable using ceramic/
photopolymer blends
Levy et al. (1997), Tesavibul et al. (2012), 
Scalera et al. (2014), and Sabree et al. (2015)
SLS High accuracy; good mechanical strength; a 
broad range of materials can be processed
High temperatures during process; 
trapped powder is difficult to remove
Hutmacher et al. (2004)
3-D printing Fast processing; no toxic components; 
water used as a binder; tunable mechanical 
properties
Trapped powder issue Yun et al. (2007), Fu et al. (2011a,b), Garcia 
et al. (2011), Wu et al. (2011a), Bose et al. 
(2013), and Liu et al. (2013)
Sponge replication Reticulated open-cell material; applicable to 
any ceramic material that can be dispersed 
into a suspension; no toxic chemicals needed
Mechanical properties might be poor Chen et al. (2006), Zhu et al. (2008), Vitale-
Brovarone et al. (2009), Zhu and Kaskel 
(2009), Wu et al. (2010), Baino et al. (2013), 
and Baino and Vitale-Brovarone (2014)
Starch consolidation Environment-friendly; low-cost Pores might be poorly interconnected Lyckfeldt and Ferreira (1998) and Vitale-
Brovarone et al. (2004, 2005)
Thermal bonding of short 
glass fibers
Simple; no need for any additional material 
except fibers and mold; glassy scaffolds can 
be obtained
Mechanical properties might be poor Pirhonen et al. (2003), Moimas et al. (2006), 
Gu et al. (2013), and Tirkkonen et al. (2013)
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transferred to an oven for drying, burning-out of the polymer, 
and sintering of ceramic particles. The resulting ceramic foam 
exhibits higher strength magnitudes compared to other con-
ventional methods due to the less flawed structure (low amount 
and size of the defects) and dense struts and walls produced. 
However, the porous structure results poorly interconnected and 
non-homogeneous (Sepulveda and Binner, 1999). The final cell 
size distribution and strut thickness can be engineered during 
processing by controlling enlargement of bubbles and thinning 
of lamellas (cell walls) upon the induction period. This can be 
efficiently done by altering the concentration of the initiator and 
the catalyst; however, other parameters such as temperature and 
pH have also been found to play a significant role (Sepulveda and 
Binner, 1999). Another advantage of this technique is the ability 
to produce porous scaffolds with a high degree of complexity. The 
casting process, in fact, allows shaping forms/profiles without the 
need of machining. Additionally, if further details are required, 
the dried green foams are strong enough to withstand machining 
(Colombo, 2006). Gel-cast foaming has also been combined with 
the foam replica method (the latter described in Section “Sponge 
Replica Method”) to produce HA scaffolds with interconnected 
pores (Ramay and Zhang, 2003). Gel-cast foaming can also 
involve the use of gelling polymers (e.g., gelatin) with no need for 
initiator and catalyst (e.g., gelation can take place with a decrease 
in temperature); in this case, a supplementary freeze–drying 
step before sintering is necessary (Novajra et al., 2015a,b). The 
structure of a scaffold produced by gel-cast foaming is shown in 
Figure 2.
A third option is sol–gel foaming, a process that combines 
sol–gel technology  –  a chemical-based wet synthesis route, 
which involves the conversion of a solution containing ceramic 
precursors (sol) into a network of covalently bonded silica via 
inorganic polymerization reactions  –  and mechanical frothing 
(Akkus et al., 2002). After heat treatment, a glass or glass–ceramic 
construct can be obtained exhibiting a hierarchical structure with 
interconnected macropores for tissue ingrowth (10–500  μm) 
and a mesoporous texture (channels in the 2–50 nm range) that 
promotes cell adhesion and adsorption of biological metabolites 
while intensifying the rate of surface reactions in vitro and in vivo 
(especially the formation of surface HA layer) (Jones and Hench, 
FiGURe 2 | Bioactive glass–ceramic scaffold obtained by gel-cast 
foaming followed by a freeze–drying step before sintering (courtesy 
of Giorgia Novajra).
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2004). The latter feature is tuned by including in the sol a surfactant 
that acts as a template for supramolecular self-assembly; this 
process is also referred to as evaporation-induced self-assembly 
(EISA) (Brinker et al., 1999). The steps involved in the process are 
(1) preparation of a sol from a mixture of distilled water, appro-
priate precursors (metal alkoxides, such as tetraethylorthosilicate 
and triethylphosphate), salts (CaNO3), and a hydrolysis catalyst 
(dilute acid), (2) foaming by vigorous agitation with the addition 
of a gelling agent, a surfactant, and distilled water, (3) casting 
of foamed mixture into molds, (4) aging to achieve gelation of 
the sol, (5) removal of the solvent by drying at low temperature, 
and (6) sintering to obtain porous components. Highly bioac-
tive bone-like 3-D scaffolds can be successfully obtained by this 
method (Jones and Hench, 2004); an unavoidable limitation is the 
intrinsic brittleness of the porous product due to the nanoporous 
texture, which poses critical issues in view of the safe implanta-
tion of the device (too low mechanical properties) (Baino and 
Vitale-Brovarone, 2011).
Starch Consolidation
This method uses corn-, rice-, or potato-derived starch granules 
both as a pore former and a binder to fabricate porous ceramics. 
The main advantages of this processing technique are its low cost 
and its environment-friendly nature.
The process involves mixing of starch granules, ceramic pow-
der, and distilled water to obtain a suspension that is continuously 
stirred and maintained at 60–80°C. In this temperature range, 
starch undergoes swelling due to water absorption, leading to 
a gel-like material that, after consolidation, is thermally treated 
to burn-out the organic phase and to sinter the ceramic matrix. 
Low dimensional changes occur during consolidation and dry-
ing, which ease the control of the ultimate dimensions of the 
component after sintering (Lyckfeldt and Ferreira, 1998).
Historically, this method was one of the first used to process 
bioactive glasses in a porous form (Vitale-Brovarone et  al., 
2004, 2005); albeit the mechanical properties of the resulting 
glass–ceramic scaffolds (compressive strength about 6 MPa) were 
comparable to those of cancellous bone (2–12 MPa), the porosity 
was too low (40 vol.%) and poorly interconnected for deeming 
an eventual clinical application. Therefore, other polymer phases 
(apart from starch) have been experimented as a pore former for 
tissue engineering bioactive glass scaffolds.
Organic Phase Burning-Out
The organic phase burning-out (or space-holder method) is 
another strategy for producing porous scaffolds. In this method, 
ceramic powders are mixed together with a solid polymeric phase 
of synthetic [e.g., poly(methyl methacrylate) or polyethylene 
microbeads] (Baino et al., 2009) or natural origin (e.g., rice husk) 
(Wu et  al., 2009). Afterwards, the blend is pressed to obtain a 
“green body” and thermally treated at high temperature. Upon 
heating, the polymeric particles that fill in the space within the 
volume of the component decompose, whereas the inorganic 
particles sinter, leading to a porous body displaying a negative 
replica of the original sacrificial template (Colombo, 2006; Baino 
and Vitale-Brovarone, 2011). Since sintering requires higher tem-
peratures than pyrolysis, the ceramic matrix has to be partially 
consolidated before removal of the sacrificial material, so that the 
porous structure does not collapse during the polymer removal 
step; therefore, binders are generally incorporated in the mixture 
(Studart et al., 2006).
Both closed and open cell ceramic foams can be obtained, 
depending on the volume fraction and nature (significantly 
affecting the amount of gas developed during burning-out) of 
the sacrificial polymer. Nevertheless, pore interconnectivity is 
generally low due to the difficulty in maintaining a homogene-
ous distribution of the polymer spheres (Baino et al., 2009; Wu 
et al., 2009). Due to the presence of thick, dense struts, scaffolds 
produced by this method can exhibit high mechanical strength, 
even comparable to that of cortical bone (Baino et al., 2009).
In order to attain a highly porous structure, a large propor-
tion of the polymeric phase in the starting mixture is necessary. 
This typically causes the development of a large amount of gas 
during heating that can cause the formation of cracks in the 
ceramic body (Bretcanu et al., 2014). Thus, the process needs to 
be attentively controlled to avoid the formation of defects in the 
final component.
Sponge Replica Method
The sponge replication method was patented by Schwartzwalder 
and Somers (1963) and, since then, it has become the most popu-
lar and effective method of producing foam-like ceramic scaf-
folds for tissue engineering. This success is primarily attributed 
to the simplicity and flexibility of the method, as it is applicable 
to any ceramic material that can be appropriately dispersed into 
a suspension. It has been observed that the reticulated open-cell 
structure (i.e., consisting of interconnected voids surrounded 
by a web of ceramic ligaments, the struts) that can be obtained 
using the foam replica method is the most suitable for bone tis-
sue engineering scaffolds (Table 1) as it closely mimics the 3-D 
trabecular architecture of cancellous bone (Figure 3). Another 
key strength of this method is that the starting sponge can be 
easily cut and conformed to match the size and shape of the 
tissue defect, so that – at least ideally – personalized scaffolds 
FiGURe 3 | Photographs of two commercially available hydroxyapatite 
cylindrical scaffolds with different porosity produced by sponge 
replica method. The length of the scaffolds is about 15 mm. Image adapted 
from © Dorozhkin (2010a).
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could be fabricated according to the patient’s clinical needs 
(Vitale-Brovarone et al., 2009).
This process involves the impregnation of an open-cell porous 
template of synthetic (typically a polyurethane sponge) or natural 
material (e.g., marine sponge) with a slurry of finely divided 
ceramic powder and a binding agent [e.g., poly(vinyl alcohol), 
colloidal silica]. The sponge is then squeezed to remove the excess 
slurry and enable the coating of the sponge struts with a thin layer 
of the slurry. After drying, the coated template is pyrolyzed while 
the remaining ceramic coating is sintered at higher temperatures 
to obtain a porous ceramic exhibiting the same architecture as 
the sacrificial template (positive replica). Therefore, the morpho-
logical characteristics of the ceramic foam are directly related 
to those of the polymeric template used (Schwartzwalder and 
Somers, 1963).
The most crucial step in the process is the production of a 
uniform coating on the polymeric structure. In more detail, the 
affecting factors are (1) the rheology of the impregnating suspen-
sion and (2) its adhesion on the struts of the polymeric sponge. 
The suspension should be sufficiently fluid to allow penetration 
into the cells of the sponge upon compression and expansion, 
but viscous enough to avoid drainage of the remaining coating. It 
is also worth mentioning that incomplete removal of the excess 
slurry leads to a structure with a certain degree of closed porosity 
(Schwartzwalder and Somers, 1963; Colombo, 2006).
The sponge replica method has been recently applied in 
combination with EISA method to produce hierarchical porous 
bioactive glass scaffolds, where a polyurethane foam and a 
surfactant were used as co-templates for scaffold macropores 
and mesopores, respectively (Zhu et al., 2008; Zhu and Kaskel, 
2009). These scaffolds are highly bioactive but exhibit dramatic 
brittleness due to the presence of the mesoporous texture. Wu 
et al. (2010) tried to improve the mechanical properties of these 
hierarchical porous constructs by depositing a silk coating on the 
strut, but their compressive strength still remained too low (few 
hundreds of kilopascal) for deeming a safe clinical application.
Solid Freeform Fabrication
Solid freeform fabrication, also referred to as rapid prototyping, 
denotes a set of emerging moldless techniques that use layer-wise 
manufacturing strategies to create scaffolds with customized 
external shape and pre-designed internal architecture (strut 
features, pore arrangement, size, and distribution) directly from a 
computer-generated 3-D model. This model is a 3-D reconstruc-
tion of the patient-specific tissue defect, which can be acquired 
from patient’s computed tomography data or magnetic resonance 
imaging. Further details regarding the micro-environment can be 
developed by making use of computer-aided design (CAD). One 
of the main advantages of SFF technology is the ability to fabricate 
components with highly reproducible architecture and composi-
tional variation (Hutmacher et al., 2004). This set of techniques is 
particularly valuable to produce functionally graded bioceramic 
and composites (Miao and Sun, 2010).
A number of SFF strategies have been adopted to manufacture 
scaffolds for tissue engineering applications (Hollister, 2005).
Stereolitography (SLA) uses a blend of ceramic powders and 
a photocurable monomer. A UV laser beam, which cures the 
monomer, is selectively scanned over the surface of the blend fol-
lowing the cross-sectional profiles of the CAD model; subsequent 
layers are built directly on top of previously cured layers with new 
layers of blend being deposited. After this step, the material not 
cured by the laser can be drained away and sintering is performed 
to produce the final object (Levy et al., 1997; Hutmacher et al., 
2004). Fabrication of HA and amorphous calcium phosphate 
scaffolds for hard tissue repair using SLA has been extensively 
reported in the literature (Hollister, 2005; Scalera et  al., 2014). 
Recently, Tesavibul et al. (2012) proposed the use of a lithographic 
method to fabricate 45S5 Bioglass®-derived scaffolds with highly 
ordered pore arrangement. Stereolitographic fabrication of wol-
lastonite containing glass–ceramic scaffolds with high-strength 
properties was also reported by Sabree et al. (2015) (Figure 4).
Selective laser sintering (SLS) is a technique that employs 
a CO2 laser beam to sinter thin layers of powdered ceramic 
materials to form 3-D objects. The laser beam is scanned over the 
powder bed following CAD data, thus raising the temperature 
of powders only in selected areas. In this way, particles fuse 
together and subsequent layers can be built directly on the top of 
the previously sintered material. Scaffolds from nano-HA and β-
TCP as well as ceramic/polymer composites have been prepared 
using SLS technology (Hutmacher et al., 2004). Gao et al. (2014) 
FiGURe 6 | 3-D printing of calcium sulfate cylindrical scaffolds: 
scaffold design (front and top views) using Solidworks and 3-D 
printed specimen (sample length 12 mm). Image reproduced from © 
Farzadi et al. (2015).
FiGURe 5 | Calcium phosphate (HA/β-TCP = 60/40 wt.%/wt.%) 
scaffolds fabricated by selective laser sintering: the scaffold 
architecture in 3-D is built up layer by layer. Images adapted from © 
Gao et al. (2014).
FiGURe 4 | wollastonite containing glass–ceramic scaffolds produced 
by stereolithography: (A) original mold fabricated by 
stereolithography, filled mold and final sintered scaffold structure 
showing shrinkage after sintering (1200°C); (B,C) SeM images 
showing a general view of the scaffold structure and morphology 
(nominal pore size of 400 and 500 μm, respectively). Images adapted 
from © Sabree et al. (2015).
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recently reported the fabrication of biphasic calcium phosphate 
scaffolds by SLS, too (Figure 5).
A third very valuable option to produce porous ceramic 
scaffolds is 3-D printing (3DP), developed in the early 1990s at 
MIT. 3DP is a powder-based technology that employs a printer 
head  –  which moves in accordance to the object profile being 
generated by a computer system  –  to eject and deposit binder 
onto the powder surface and bonds the granules in the selected 
regions. Subsequently, a fresh layer of powder is laid down by a set 
of rollers. The cycle continues until the whole object is completed 
and at this point an airflow is used to remove unbound powder. 
The objects are sintered at high temperatures to achieve sufficient 
strength of the bodies and to remove the binder safely. Binders 
can be either organic (e.g., starch based) or water based. A wide 
variety of ceramic materials for tissue engineering have been 
processed using 3DP, such as HA, calcium phosphates, calcium 
sulfate, bioactive glasses, and ceramic composites, with a regular 
3-D architecture and pore arrangement (Figure  6); however, 
extensive optimization is needed to process good quality parts 
with 3DP for any new material/composition, which is – together 
with the quite high cost of instrumentation – the major drawback 
of this approach (Bose et al., 2013).
Methods referred to as robocasting and direct ink-write 
assembling belong to the broad class of 3DP techniques. In this 
regard, bioactive glass scaffolds with a regular arrangement of 
pores in 3-D and extraordinarily high mechanical performances 
in compression and flexure were proposed for possible application 
in the substitution of cortical bone and load-bearing segments of 
the skeleton (Fu et al., 2011a,b; Liu et al., 2013).
3-D printing has also been applied to fabricate MBG scaffolds. 
Yun et al. (2007) and Garcia et al. (2011) prepared hierarchical 3-D 
porous MBG scaffolds using a combination of double polymer 
template and rapid prototyping techniques. In their study, they 
mixed MBG gel with methylcellulose and then printed, sintered 
at 500–700°C to remove polymer templates and obtained MBG 
scaffolds. Although the obtained MBG scaffolds have uniform 
pore structure, their mechanical strength is compromised 
because of the incorporation of methylcellulose, which results 
in some micropores. Recently, Wu et al. (2011a) reported a new 
facile method to prepare hierarchical and multi-functional MBG 
scaffolds with controllable pore architecture, excellent mechani-
cal strength, and mineralization ability for bone regeneration 
FiGURe 7 | Resorbable glass fibrous scaffold obtained by thermal 
bonding of short glass fibers (courtesy of Giorgia Novajra).
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by a modified 3DP technique using poly(vinyl alcohol) as a 
binder. The obtained 3DP MBG scaffolds possess a compressive 
mechanical strength (16 MPa), which is about 200 times that of 
the MBG scaffolds prepared using a traditional polyurethane 
foam as a template.
Thermal Bonding of Short Glass Fibers
Porous 3-D scaffolds can also be obtained using glass fibers as 
a starting material. The fibers, with diameters typically ranging 
from tens to few hundreds of micrometers, are cut and disposed 
into a mold in a random arrangement with porosity originating 
from the free space between them. Then, a thermal treatment 
allows this porous structure to be stabilized by thermally bonding 
(sintering) the glass fibers in order to obtain glass scaffolds. The 
scaffolds produced by this method show a high degree of pore 
interconnectivity and the final scaffold structure can be tailored 
acting on the fiber size, the sintering time, and temperature 
(Pirhonen et al., 2003; Moimas et al., 2006).
Since 45S5 Bioglass® is not easy to draw into fibers without 
devitrification due to its narrow working range, other glass for-
mulations that can be easily spun have been proposed in the lit-
erature for fibrous scaffold production, in particular, silicate (e.g., 
13–93, 9–93) and borate bioactive glasses (e.g., 13–99B3) as well 
as mixtures of them (Gu et al., 2013). A porous scaffold made of 
glass fibers with nominal composition 11.1–12.0 Na2O, 15.0–17.1 
K2⋅O, 2.8–3.3 MgO, 12.7–15.2 CaO, 2.7–3.8 P2O5, 1.0–1.4 B2O3, 
0.0–0.6 TiO2, and 48.5–52.0 SiO2 wt.% (Tirkkonen et al., 2013) is 
currently available on the market (Inion BioRestore™, Inion Oy, 
Tampere, Finland) as a graft material (porous morsels) for bone 
defect restoration. Research studies on thermally bonded phos-
phate glass fibrous scaffolds are currently ongoing (Figure 7).
Processing Technologies for Bioceramic 
Containing Composite Scaffolds
Numerous fabrication techniques have been described to produce 
3-D porous bioceramic/polymer composite scaffolds, including 
space-holder, gas foaming, thermally induced phase separation 
(TIPS), and SFF. These methods have been extensively reviewed in 
the literature (Rezwan et al., 2006; Mohamad Yunos et al., 2008). 
Among all, TIPS can be considered the technique of choice if scaf-
folds with highly oriented porosity need to be prepared. This pore 
structure differs considerably from the isotropic structure and 
equiaxed pores that are typically obtained by the “conventional” 
methods. The TIPS process has been widely used to produce 
composite scaffolds based on PLGA and PDLLA foams contain-
ing 45S5 Bioglass® particles as bioactive inclusions (Maquet et al., 
2003, 2004; Verrier et al., 2004; Blacher et al., 2005).
Polymer-coated bioceramic scaffolds can be produced by a 
dipping method that involves the dipping of a bioceramic scaffold 
in a polymer solution followed by drying in air (Bretcanu et al., 
2007); the polymer coating is useful to improve the mechani-
cal properties of the scaffold, especially the fracture toughness 
(Rehorek et al., 2013).
A dip-coating approach has been also reported to apply a 
biomimetic calcium phosphate layer on metal scaffolds (TiNbZr 
alloy) to improve their biocompatibility (Wang et al., 2009).
A highly versatile and promising approach to produce bioce-
ramic scaffolds coated with different materials (polymers, other 
ceramic phases) is the electrophoretic deposition (EPD), which 
uses the electrophoresis mechanism for the movement of charged 
particles suspended in a solution under an electric field, in order 
to deposit them in an ordered manner on a substrate to develop 
thin and thick films and coatings (Boccaccini et al., 2010). Fiorilli 
et al. (2015) reported the successful EPD of MBG onto a strong, 
nearly inert glass–ceramic scaffold to obtain a bioactive high-
strength construct for load-bearing applications in bone tissue 
engineering. The use of EPD to produce carbon nanotube (CNT) 
coatings for smart applications in tissue engineering has been 
also investigated, for example, Meng et al. (2011) incorporated 
CNTs into 45S5 Bioglass®-derived glass–ceramic scaffolds by 
EPD and cultured mesenchymal stem cells on the constructs 
with and without electrical stimulation, and they observed that 
the electrical conductivity associated with the CNTs can promote 
the proliferation and differentiation of the cells attached onto the 
scaffold.
CLiNiCAL APPLiCATiONS OF 
BiOCeRAMiC SCAFFOLDS: PReSeNT 
AND FUTURe
An overview of the applications of bioceramic scaffolds in 
medicine is summarized in Table 3. As a result of biomechanical 
limitations, bioactive glasses, glass–ceramics, and calcium phos-
phates are mainly used in low-/non-load-bearing applications 
or compressive load situations in solid or powder form, such as 
bone restoration and augmentation, middle ear repair, vertebral, 
and iliac crest replacements (Hench, 1998; Dorozhkin, 2010a). 
Thermal-sprayed HA coatings on metal joint prostheses are 
also used in the clinical practice by surgeons (Sun et al., 2001). 
Bioactive glass–ceramic porous coatings on alumina acetabular 
cups have been recently proposed to improve osteointegration 
of prosthetic devices (Vitale-Brovarone et al., 2012b; Baino et al., 
2015, 2016a).
TABLe 3 | Applications of bioceramic scaffolds in tissue engineering.
Field of application Material/scaffold involved Recipient Stage of use/research Reference
Bone defect repair Porous scaffolds made of HA, biphasic 
calcium phosphates, bioactive glasses 
(e.g., 45S5 Bioglass®, 13–93)
H Clinical use (the products are 
FDA approved)
Hench (1998) and Dorozhkin (2010a, 
2012)
Joint prosthesis Bioactive glass–ceramic coating with 
trabecular architecture on bioceramic 
acetabular cup
– Promising experimental results 
achieved in the framework of 
the EC-funded project “MATCh.” 
Neither in vitro nor in vivo tests 
are currently available in the 
literature
Vitale-Brovarone et al. (2012a,b) and 
Baino et al. (2015, 2016a,b)
Orbital implant Porous spheres made of alumina (the 
so-called “Bioceramic implant”), HA 
(examples of commercial products: 
coralline HA – Bioeye®, synthetic 
HA – FCI3, bovine HA – Molteno 
M-sphere) or 45S5 Bioglass®/polyethylene 
composite (Medpor-Plus)
H HA and alumina implants, being 
FDA approved since many years, 
are routinely used in the clinical 
practice
Naik et al. (2007) and Baino et al. 
(2014)
Early uses of 45S5 Bioglass®/
polyethylene composite spheres 
in the clinical practice
Wound healing 45S5 Bioglass®/polymer composite 
meshes
AS No study involving human 
patients available
Day et al. (2004) and Rai et al. (2010)
Skin tissue engineering Fibrous constructs comprising MBG fibers 
as such or in combination with a polymer
– No biological study available Hong et al. (2010) and Jia et al. 
(2011)
Lung tissue engineering Sol–gel glass foams or PDLLA/45S5 
Bioglass® porous composites
IV No in vivo study available Tan et al. (2002) and Verrier et al. 
(2004)
Muscle tissue engineering Phophate glass fibrous constructs – No in vivo study available Ahmed et al. (2004), Shah et al. 
(2014), and Shah et al. (2015)
Peripheral nerve repair Bioactive glass fibrous constructs AS No study involving human 
patients available
Vitale-Brovarone et al. (2012a) and 
Kim et al. (2015)
H, humans; AS, animal study; IV, in vitro tests with cells.
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All the applications of bioactive ceramics take the advantage 
of bioactivity and minimize mechanical-property requirements, 
which may be an issue in the case of highly porous implants. 
Stock porous blocks of various size made of HA, (biphasic) 
calcium phosphate, and a few bioactive glasses (Table  3) are 
currently marketed worldwide and clinically implanted in 
humans for the repair of small bone defects; these implants 
can be contoured intraoperatively by the surgeon to match the 
size/shape of the defect. SFF-derived custom-made HA porous 
scaffolds are produced if a high accuracy on the size or complex 
shapes are needed, such as implants for orbital floor repair 
(Levy et  al., 1997). Trabecular bone  –  which can be actually 
considered a natural bioceramic-based composite – from bone 
banks is also used as a restorative material (Schlickewei and 
Schlickewei, 2007).
A special non-osseous application where (porous) bioce-
ramics are widely used is the fabrication of orbital implants 
for enucleated patients. Porous spherical implants (scaffolds) 
made of bovine, coralline, and synthetic HA as well as alumina 
are routinely implanted upon anophthalmic socket surgery as 
they are biocompatible and allow fibrovascularization within 
their pore network (Baino et al., 2014). Early human trials with 
45S5 Bioglass®/polyethylene composite porous orbital implants 
showed promising results, including an enhanced implant fibro-
vascularization compared to other available devices (Naik et al., 
2007), which can be due to the angiogenic effect of bioactive glass.
In recent years, the use of bioceramic and composite scaf-
folds  –  usually comprising bioactive glass as an inorganic 
phase – has also been proposed for some emerging applications in 
contact with soft tissues. In this regard, the angiogenic potential of 
bioactive glasses has opened new perspectives in skin tissue engi-
neering. Day et al. (2004) first showed in vitro (using fibroblasts) 
and in  vivo (in rats) the ability of 45S5 Bioglass® incorporated 
into PGA meshes to increase scaffold neovascularization, which 
would be highly beneficial during the engineering of larger soft 
tissue constructs. Nano-sized 45S5 Bioglass® particles were also 
used by Rai et  al. (2010) in the fabrication of a novel poly(3-
hydroxyoctanoate)-based composite scaffold for wound dressing: 
the incorporation of bioactive glass nanoparticles accelerated 
blood clotting time and enhanced the wettability, surface rough-
ness, and overall biocompatibility of the scaffold.
Hong et  al. (2010) investigated the use of ultrathin MBG 
hollow fibers (diameter around 600  nm), fabricated by elec-
trospinning combined with a phase-separation inducing agent 
[poly(ethylene oxide)], as a multifunctional system for skin 
tissue engineering (support to the regenerated tissue and release 
of anti-inflammatory drugs) when organized in the form of 3-D 
macroporous membranes. MBGs were also mixed with chitosan 
to produce composite films by freeze–drying for possible use as 
hemostatic membranes for skin repair (Jia et al., 2011).
Bioactive glass scaffolds have been also proposed for lung 
tissue engineering applications. In a study by Tan et al. (2002), 
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sol–gel-derived bioactive glass foams with surface modifica-
tions to include amine or mercaptan groups and/or coated with 
laminin were manufactured and placed in culture with murine 
lung epithelial cells to determine the best conditions to promote 
cell growth and proliferation. Based on histological examination 
of the cell cultures, there was full colonization of the foams by 
the lung cells and it was shown that the laminin-coated, amine-
modified foams were most effective in promoting cell growth and 
attachment.
In another study, Verrier et  al. (2004) proposed the use 
of PDLLA/45S5 Bioglass® porous composites for lung tissue 
engineering performing in  vitro biocompatibility assays with a 
human lung carcinoma A549 cell line. Two hours after cell seed-
ing, a general increase of cell adhesion according to the increased 
content of Bioglass® (0, 5, and 40 wt.%) in the PDLLA foams was 
observed, but cell proliferation studies over a period of 4 weeks 
revealed a better aptitude of A549 cells to proliferate on scaffolds 
containing only 5 wt.% of glass. These results seem to indicate the 
possibility of using bioactive glasses in lung tissue engineering 
approaches, although a lot of future work, including testing with 
the different cell types found in this complex tissue, is necessary 
for further advancements.
The results reported by Verrier et  al. (2004) demonstrate 
that the concentration of bioactive glass in tissue engineering 
polymer-based constructs should be always optimized depend-
ing on the considered tissues that we want to regenerate. This 
dose-dependent effect was also observed in another study by the 
same research group, in which PLGA/45S5 Bioglass® composite 
tubular foam scaffolds (porosity about 93 vol.%, size of intercon-
nected macropores in the 50–300 μm range, wall thickness within 
1.5–3.0 mm) were fabricated via TIPS (Boccaccini et al., 2005); 
the authors proposed the use of the produced constructs for the 
regeneration of tissues requiring a tubular shape scaffold, such as 
blood vessels and trachea.
The research group led by Prof. Jonathan Knowles also car-
ried out a few studies with phosphate glasses for applications 
in muscle regeneration. Ahmed et al. (2004) found that CaO–
Na2O–Fe2O3–P2O5 glass fibers allowed attachment, proliferation, 
and differentiation of conditionally immortal muscle precursor 
cell line with the formation of myotubes along the axis of the 
fibers. Shah et al. (2005) found that human masseter-derived cells 
seeded on a 3-D mesh construct not only attached and prolifer-
ated but also migrated along the fibers forming multinucleated 
myotubes. It was also found that 3-D aligned fiber scaffolds were 
able to support unidirectional cell alignment and caused an 
up-regulation of genes encoding for myogenic regulatory factors 
(Shah et al., 2014), even when the glass fibers were embedded 
into a collagen gel to form a composite scaffold (Shah et  al., 
2015). Glass fibers were also found to support and direct axonal 
regeneration both in vitro and in vivo (Vitale-Brovarone et al., 
2012a; Kim et al., 2015).
Because of their ability to bond to soft tissues and to elicit 
desirable biological responses, such as angiogenesis, bioactive 
glasses have been recently proposed in a non-porous form for 
some other interesting non-osseous applications. A few examples 
concern the use of bioactive glass particulate for the treatment 
of gastric ulcers, injectable radioactive glasses for killing cancer 
cells in liver tumor, glass/polymer composites for cardiac tissue 
engineering, and glass/polymer tubes for peripheral nerve regen-
eration. These applications, not restricted to porous scaffolds, 
have been recently reviewed by some leading scientists in the field 
(Baino et al., 2016b; Miguez-Pacheco et al., 2015a,b).
SUMMARY AND OUTLOOK
Progress in tissue engineering has led to the development of 
porous materials designed and manufactured to act as a scaffold 
for the growth of new tissue in order to restore the natural state 
and function of diseased parts of the body. Bioceramics have 
demonstrated to be highly suitable materials for tissue engineer-
ing scaffolds and developments in processing methods have 
provided a mean to control the 3-D architecture of such scaffolds. 
In spite of remarkable advances, bioceramics have not yet reached 
their full potential but research is ongoing.
Besides “traditional” use for osseous defect repair, a variety of 
innovative applications are emerging; for instance, recent studies 
have interestingly highlighted the suitability of bioactive glasses 
and glass–ceramics for wound healing applications and soft-
tissue engineering (Baino et  al., 2016b; Miguez-Pacheco et  al., 
2015a). For these applications, where softer and more flexible 
materials are needed, inorganic–organic hybrids could be an even 
better solution. These materials are interpenetrating networks of 
inorganic and organic components that interact at a molecular 
level; they behave as a single phase and, thus, degrade as one 
material (overcoming the main drawback related to composite 
biomaterials). Their mechanical properties as well as bioactivity 
can be tailored by varying the constituents and synthesis/process-
ing parameters (Jones, 2009, 2013).
The use of porous bioceramics as parts of a complex prosthetic 
devices and not only as a bone-filling material for the restoration 
of osseous defects but also as a “warm” challenge that has recently 
arisen. In this regard, a fascinating approach that has been put 
forward is the use of glass-derived scaffolds as osteointegrative 
trabecular coatings on ceramic acetabular cup of hip joint pros-
thesis. These coatings are expected to induce biological fixation 
of the prosthesis while eliminating the need for invasive screws, 
cements, or threading to fix implants in place (Vitale-Brovarone 
et  al., 2012b; Baino and Vitale-Brovarone, 2015b; Baino et  al., 
2015, 2016a).
The development of multifunctional bioceramics that 
combine the “conventional” properties of 3-D porous bioactive 
scaffolds and the added value of therapeutic ion release also has 
great potential. In this regard, bioactive glasses can be doped 
with various trace elements to provide a smart strategy for the 
controlled delivery of ions in situ, such as Sr, Cu, Zn, Ga, or Co, 
which may lead to therapeutic effects upon their release into the 
cellular environment (e.g., promotion of angiogenesis, antibacte-
rial action) (Hoppe et al., 2011; Mourino et al., 2012).
Fabrication of bioceramic components with hierarchical 
porosity has also recently attracted the interest of biomaterials 
scientists (Colombo et al., 2010). The use of MBGs either in the 
form of macro-/mesoporous scaffolds or as coatings can add valu-
able extra-functionalities to the (base) scaffold. The mesoporous 
texture and high surface area of these glasses intensify the rate of 
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surface reactions, leading to a faster release of ionic species upon 
glass dissolution. Therefore, not only the classical bioactivity 
mechanism is speeded up (fast formation of a surface layer of 
HA that allows strong bone bonding in vivo) but also therapeutic 
metal ions, previously incorporated within the glass network, 
can be quickly released upon contact with biological fluids (Wu 
and Chang, 2014). The solubility rate of MBGs can be tailored 
by controlling the textural parameters (e.g., mesopore structure 
and size) and by changing the glass composition so that they dis-
solve at controlled rates matching those of the tissue growth. A 
further added value is using MBGs as carriers for the controlled 
delivery of drug molecules that can be incorporated in the mate-
rial mesopores (Arcos and Vallet-Regí, 2013), thereby creating a 
multifunctional tissue engineering implantable device.
New strategies for scaffold fabrication are also emerging both 
to improve the scaffold performance and to develop ever more 
sustainable processing routes. For instance, highly porous bioac-
tive glass scaffolds were successfully produced by an innovative 
method based on preceramic polymers containing micro- and 
nano-sized fillers (Fiocco et al., 2014). Silica from the decomposi-
tion of the silicone resins reacted with the oxides deriving from 
the fillers, yielding glass–ceramic components after heating at 
1000°C. Despite the limited mechanical strength, the obtained 
samples possessed suitable porous architecture and promising 
biocompatibility and bioactivity, as testified by preliminary 
in vitro tests. This method has also been very recently applied to 
fabricate wollastonite/diopside composite foams for bone tissue 
engineering applications (Fiocco et al., 2015).
If an oriented pore microstructure and high mechanical prop-
erties are required, freezing of ceramic slurries can represent a 
valuable, relatively simple strategy to this aim (Liu et al., 2012).
In summary, new, continuous advances in scaffold processing 
technologies and novel emerging applications of porous scaffolds 
in both hard- and soft-tissue engineering bring further honor to 
the long history of ceramics in medicine. We forecast a bright 
future for bioceramics, which will indeed provide an ever increas-
ing contribution in improving the quality of life of mankind.
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